Development of measurement tools
The Australian Centre for Behavioural Research in Diabetes
570 Elizabeth Street
Melbourne 3000
Victoria
AUSTRALIA
+61 (0)3 8648 1850
jspeight@acbrd.org.au
Development of measurement tools, Diabetes related distress, Fear of hypoglycemia, Health care, Health economics, Health promotion, Hypoglycemia unawareness, Intervention, Meta-analyses / systematic reviews, Neuropsychological problems (related to hypo), New technologies, Psychological adjustment / Quality of life, Psychological insulin resistance, Qualitative research, Quantitative research, Self-management / lifestyle, Social bias / prejudice, Special groups, Survey research, Type 1 diabetes, Type 2 diabetes
570 Elizabeth Streeth, Melbourne, Victoria, AUSTRALIA 3000
+61 (0)3 8648 1834
aventura@acbrd.org.au
Researcher
Adults (40-64 yrs), Anxiety, Co-morbidities, Cognitive behavioral therapy, Coping, Depression, Development of measurement tools, Diabetes related distress, E-health, Eating problems, Empowerment, Fear of hypoglycemia, Fear of injecting / self-testing, Health cognitions / Illness perceptions, Health promotion, Internet interventions, Mindfulness, Older adults (≥ 65 yrs), Partners of people with diabetes, People with mental illness, Psychotherapy, Qualitative research, Quantitative research, Relation or family problems, Resilience, Social bias / prejudice, Stress in general, Stress management, Survey research, Type 1 diabetes, Type 2 diabetes, Women with diabetes, Young adults (18-39 yrs)
Blaak 6 63011 TA, Rotterdam, The Netherlands
63537030461
p.winterdijk@diabeter.nl
Medical Care
Adolescents (13-17 yrs), Anxiety, Blood glucose monitoring, Co-morbidities, Depression, Development of measurement tools, Diabetes education, Diabetes related distress, Diet, Empowerment, Exercise, Health cognitions / Illness perceptions, Infants (0-3 yrs), Insulin injection, Insulin pump therapy, MODY, Motivation, Pre-schoolers (4-6 yrs), Quality of care, Quality of life, Quality of Life, Resilience, Risk assessment, Satisfaction with care, School-aged children (4-12 yrs), Screening, Type 1 diabetes, Young adults (18-39 yrs)